NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,401,689 | -41.3% | 336,135 | -36.4% | 0.75% | -41.6% |
| Q1 2023 | $9,196,571 | +47.6% | 528,235 | +356.4% | 1.28% | +48.8% |
| Q4 2020 | $6,232,000 | +50.2% | 115,748 | +2.9% | 0.86% | +12.2% |
| Q3 2020 | $4,150,000 | -1.4% | 112,508 | -26.2% | 0.77% | -44.7% |
| Q1 2020 | $4,208,000 | +255.4% | 152,391 | +276.6% | 1.39% | +342.4% |
| Q4 2019 | $1,184,000 | -58.7% | 40,465 | -69.1% | 0.31% | -66.3% |
| Q2 2019 | $2,869,000 | – | 130,760 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |